
National Association of Testing Authorities, Australia
Scope of Accreditation
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
Site
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
Accreditation No.
20911
Site No.
25131
Date of Accreditation
20 Feb 1990
Address
100 Mallett Street
Camperdown, NSW 2050
Australia
Contact
Assoc Prof Michael Buckland
P: +61 (02) 93510741
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Royal Prince Alfred Hospital Clinical Neuroscience Laboratories
ISO 15189 (2012)
Human Pathology
Service | Product | Determinant |
---|---|---|
Anatomical pathology - Tissue pathology - Examination of biopsy material | Brain - Whole | Presence or absence of Creutzfeldt-Jacob disease |
Brain - Whole; Spinal cord | Review and reporting of material to identify neurological diseases | |
Fresh tissue; Muscle; Nerve biopsy | In-vitro contraction test; Nerve conduction studies; Neuromuscular disorders; Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting | |
Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues; Frozen sections of fresh tissue | Detection of antigenic targets - Various |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Formalin-fixed paraffin-embedded (FFPE) tissues | Glioma panel |
MGMT promoter methylation analysis | ||
H3f3A mutation analysis | ||
BRAF mutation analysis | ||
TERT promoter mutation analysis | ||
Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20911
Site No.
25131
Print date
25 Jun 2022
END OF SCOPE